Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
7.21
-0.04 (-0.55%)
Apr 24, 2026, 4:00 PM EDT - Market closed
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $756.24 million as of April 24, 2026. Its market cap has increased by 8,693.54% in one year.
Market Cap
756.24M
Enterprise Value
663.24M
1-Year Change
8,693.54%
Ranking
Category
Stock Price
$7.21
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $756.24M, an increase of 1,236.12%. That is a compound annual growth rate of 27.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 756.30M | 113.52% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
| Sep 30, 2015 | 56.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 824.56M |
| Allogene Therapeutics | 822.11M |
| SpyGlass Pharma | 818.62M |
| Lexicon Pharmaceuticals | 771.10M |
| Forte Biosciences | 730.19M |
| Alpha Tau Medical | 711.12M |
| BridgeBio Oncology Therapeutics | 709.89M |
| Gyre Therapeutics | 705.86M |